Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - Arno Therapeutics, Inc | v434593_ex31-1.htm |
| 10-K - FORM 10-K - Arno Therapeutics, Inc | v434593_10k.htm |
| EX-32.1 - EXHIBIT 32.1 - Arno Therapeutics, Inc | v434593_ex32-1.htm |
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements of Arno Therapeutics, Inc. on Forms S-8 (File No. 333-176664 and 333-194927) of our report dated March 30, 2016, which includes an emphasis of matter paragraph regarding the Company’s ability to continue as a going concern, relating to the financial statements appearing in this Annual Report on Form 10-K of Arno Therapeutics, Inc. for the year ended December 31, 2015.
/s/ Crowe Horwath LLP
New York, New York
March 30, 2016